The particularities of acute kidney injury in critically ill patients with COVID-19

Keywords

acute kidney injury
COVID-19
risk factors
intensive care unit
mortality

How to Cite

BULAI, F., BANOV, P. and CEBAN, E. (2025) “The particularities of acute kidney injury in critically ill patients with COVID-19”, One Health & Risk Management , 6(4). doi: 10.38045/ohrm.2025.4.03.

Abstract

Introduction. Acute kidney injury (AKI) is a common complication in critically ill patients with COVID-19, associated with increased mortality. This study aimed to evaluate the incidence of acute kidney injury in COVID-19 patients hospitalized in intensive care units, identify risk factors for its development, and determine the impact of AKI on mortality and clinical outcomes.

Material and Methods. A retrospective cohort study was conducted and included patients with confirmed COVID-19 infection, admitted to the Republican Clinical Hospital “Timofei Moșneaga” between June 01, 2020, and August 31, 2020. The association between potential risk factors and AKI was assessed using relative risk (RR) with 95% confidence intervals (CI).

Results. Of the 81 patients included, 20 (24.69%) developed AKI. Significant risk factors associated with AKI included mechanical ventilation (RR = 7.96; 95% CI: 2.86–22.15, p < 0.001) and vasopressor therapy (RR = 4.12; 95% CI: 1.43–11.86, p = 0.009). The mortality rate was significantly higher in patients with AKI compared to those without AKI (90% vs. 36.06%, RR = 2.49; 95% CI: 1.85–3.36, p < 0.001).

Conclusions. Acute kidney injury is a severe complication in critically ill COVID-19 patients and significantly increases mortality among patients hospitalized in intensive care units. Identifying modifiable risk factors could help optimize management strategies and improve survival rates.

https://doi.org/10.38045/ohrm.2025.4.03

|Views: 0|


Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2025 Felicia BULAI, Pavel BANOV, Emil CEBAN

Downloads

Download data is not yet available.

ANNOUNCEMENT

Starting from July 1, 2025, the article processing fee will be 20 EUR (or the equivalent in MDL at the official exchange rate of the National Bank of Moldova). The publication fee for an accepted article will be 150 EUR (or the equivalent in MDL).

Details here:

Processing Fee
A processing fee of 20 EUR (or the equivalent in MDL) will be charged for articles accepted for scientific review by the editorial committee of the One Health and Risk Management journal.
Note: This fee will only be charged if your article has been technically reviewed and accepted.

Publication Fee
Starting from 01.07.2025, a fee of 150 EUR (or the equivalent in MDL) will be charged for articles accepted for publication.
Additionally, authors will bear the cost of English language editing/translation services if the manuscript requires intervention. The fee is 5 EUR (or the equivalent in MDL) per page edited/translated.
The total cost for English editing/translation services will be communicated by the Editorial Board after the manuscript is accepted for publication.

Payment Details:
Payments should be made in MDL to the bank account opened in the name of the Biosafety and Biosecurity Association of the Republic of Moldova.
The invoice will be issued by the end of the month in which the payment was made.

Organization: Biosafety and Biosecurity Association of the Republic of Moldova
Address: 5C A. Cozmescu Street
Fiscal Code: 1017620004120
Bank Code (SWIFT): AGRNMD2X451
IBAN: MD34AG000000022513622370